Heartflow (HTFL) Stock Price

Heartflow Price

NYSE·CLOSED
54.40
​
Market closed

Over the last 2 years Heartflow grew revenue by 60.5% annually, reaching 160.86 M USD. For Heartflow, the net margin of -72.6% is up versus -153.1% a few years ago. The consensus 12-month price target for Heartflow is 45.00 USD, about 17.3% below where the stock trades today. Of 15 analysts, 13 rate the stock a buy — an overall Buy consensus.

Heartflow stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heartflow business model & stock analysis

Heartflow Inc generates revenue through its HeartFlow Platform, which includes AI-driven software solutions for diagnosing coronary artery disease. The company's products, such as HeartFlow FFRCT Analysis and Plaque Analysis, assist physicians in managing patient care by providing personalized 3D heart models derived from CCTA scans. These tools are sold to healthcare providers and hospitals, enabling non-invasive diagnosis and treatment planning for coronary artery disease. The RoadMap Analysis offers intuitive visualization of coronary arteries, helping physicians focus on critical areas during patient reviews. The HeartFlow Platform leverages artificial intelligence and computational fluid dynamics to create detailed cardiac models, positioning Heartflow Inc as a leader in medical technology for cardiovascular diagnostics. Its commercial-stage operations focus on delivering precision care solutions that improve diagnostic accuracy and patient outcomes. Healthcare institutions purchase these AI-powered tools to enhance their diagnostic capabilities without invasive procedures.

Frequently asked questions about Heartflow

Analysts currently set an average price target of 42.83 USD for the Heartflow stock (median: 45.00 USD), implying -21.3 % versus the latest price. The consensus is based on 15 analyst ratings.

15 analysts currently rate the Heartflow stock: 13 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Heartflow to generate revenue of 248.62 M USD and earnings per share of -0.41 USD.

Converted at the current exchange rate, the Heartflow share trades at 48.41 EUR (54.40 USD).

The expected revenue of Heartflow is 248.62 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Heartflow is -35.28 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Heartflow is currently -131.49. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Heartflow stock.

The price-to-sales ratio (P/S) of Heartflow is currently 18.66. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Heartflow stock.

The Eulerpool Quality Score for Heartflow is 3/10.

The ISIN of Heartflow is US42238D1072. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Heartflow is HTFL. The ticker symbol is used to trade Heartflow shares on the stock exchange.

Fair ValueTerminal
45.15 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
190,819.70 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Aug 8, 2025
ISIN
US42238D1072
Cusip
42238D107
Market capitalization
4.63 B USDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-131.49
P/Ee 2027
-201.33
P/Ee 2028
915.86
P/Ee 2029
153.96
P/Ee 2030
88.70
P/Se
18.66
EV/EBIT
—
P/B Ratio
15.41
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-38.10 %
Last updated Nov 5, 2026, 3:32 AM

Heartflow Peer Group

All fundamentals and in-depth analysis of Heartflow

Our stock analysis for Heartflow stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Heartflow. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.